Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Contact form








 


Note! If you want an answer on a question you must specify your email address




Nicholas Ashton

Postdoctor

Nicholas Ashton
Postdoctor
nicholas.ashton@gu.se

Postal Address: Blå stråket 15, vån 3 su/sahlgrenska, 413 45 Göteborg
Visiting Address: Blå stråket 15, vån 3 su/sahlgrenska , 413 45 Göteborg


Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology (More Information)
Blå stråket 15, vån 3 SU/Sahlgrenska
413 45 Göteborg
031-342 10 00
Visiting Address: Blå stråket 15, vån 3 SU/Sahlgrenska , 413 45 Göteborg

Latest publications

Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers.
Nicholas Ashton, Marc Suarez-Calvet, Amanda Heslegrave, Abdul Hye, Cristina Razquin et al.
Alzheimer's research & therapy, Journal article 2019
Journal article

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
Pratishtha Chatterjee, Henrik Zetterberg, Kathryn Goozee, Chai K Lim, Kelly R Jacobs et al.
Journal of neuroinflammation, Journal article 2019
Journal article

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
Liu Shi, Sarah Westwood, Alison L Baird, Laura Winchester, Valerija Dobricic et al.
Alzheimer's & dementia : the journal of the Alzheimer's Association, Journal article 2019
Journal article

Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies.
Thomas Vogels, Claudia Cicognola, Nicholas Ashton, Tomas Smolek, Michal Novak et al.
Biological psychiatry, Journal article 2019
Journal article

Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals.
Andréa L Benedet, Nicholas Ashton, Tharick A Pascoal, Antoine Leuzy, Sulantha Mathotaarachchi et al.
Alzheimer's & dementia, Journal article 2019
Journal article

Biomarkers for tau pathology.
Michael Schöll, Anne Maass, Niklas Mattsson, Nicholas Ashton, Kaj Blennow et al.
Molecular and cellular neurosciences, Review article 2019
Review article

Showing 1 - 10 of 18

2019

Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers.
Nicholas Ashton, Marc Suarez-Calvet, Amanda Heslegrave, Abdul Hye, Cristina Razquin et al.
Alzheimer's research & therapy, Journal article 2019
Journal article

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
Pratishtha Chatterjee, Henrik Zetterberg, Kathryn Goozee, Chai K Lim, Kelly R Jacobs et al.
Journal of neuroinflammation, Journal article 2019
Journal article

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
Liu Shi, Sarah Westwood, Alison L Baird, Laura Winchester, Valerija Dobricic et al.
Alzheimer's & dementia : the journal of the Alzheimer's Association, Journal article 2019
Journal article

Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies.
Thomas Vogels, Claudia Cicognola, Nicholas Ashton, Tomas Smolek, Michal Novak et al.
Biological psychiatry, Journal article 2019
Journal article

Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals.
Andréa L Benedet, Nicholas Ashton, Tharick A Pascoal, Antoine Leuzy, Sulantha Mathotaarachchi et al.
Alzheimer's & dementia, Journal article 2019
Journal article

Biomarkers for tau pathology.
Michael Schöll, Anne Maass, Niklas Mattsson, Nicholas Ashton, Kaj Blennow et al.
Molecular and cellular neurosciences, Review article 2019
Review article

Showing 1 - 10 of 18

Page Manager: Webbredaktör|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?